Detalles de la búsqueda
1.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747948
2.
[Patient with TNBC with early relapse within 12 months from adjuvant treatment.] / Paziente affetta da TNBC con ricaduta precoce entro 12 mesi dal trattamento adiuvante.
Recenti Prog Med
; 115(6): 21e-25e, 2024 Jun.
Artículo
en Italiano
| MEDLINE | ID: mdl-38853738
3.
Impact of Caloric Restriction in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Prospective Case Control Study.
Nutrients
; 15(21)2023 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37960330
4.
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial.
J Clin Oncol
; 41(32): 4976-4981, 2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748109
5.
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 73, 2023 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684252
6.
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study.
Cancers (Basel)
; 16(1)2023 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201545
7.
Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison.
BMC Cancer
; 10: 28, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20122160
8.
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 10(1): 13, 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316819
9.
Correlation between NK function and response to trastuzumab in metastatic breast cancer patients.
J Transl Med
; 6: 25, 2008 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-18485193
10.
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 89, 2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37903774
11.
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.
Am J Surg Pathol
; 42(9): 1190-1200, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29975246
12.
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.
J Cancer Res Clin Oncol
; 142(3): 669-78, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26531187
Resultados
1 -
12
de 12
1
Próxima >
>>